Key statistics
On Friday, Neuropace Inc (NPCE:NMQ) closed at 7.46, 29.74% above the 52 week low of 5.75 set on Aug 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.40 |
---|---|
High | 7.55 |
Low | 7.24 |
Bid | 6.85 |
Offer | 7.90 |
Previous close | 7.39 |
Average volume | 35.89k |
---|---|
Shares outstanding | 29.20m |
Free float | 23.54m |
P/E (TTM) | -- |
Market cap | 217.81m USD |
EPS (TTM) | -1.09 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
- NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million
- NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration
- NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting
- NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference
- NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
- NeuroPace Announces RNS System Enhancements Designed to Streamline Care
- NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023
More ▼